Short Course Radiation Therapy in Palliative Treatment of Thoracic Cancer
NCT03804307 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2019-01-15
Summary
Aim of the study is to assess efficacy of a short course radiation treatment in patients with symptomatic thoracic malignant lesions
Conditions
- Thoracic Cancer
- Radiotherapy
- Palliative Care
Interventions
- RADIATION
-
standard treatment
3000 cGy in 10 daily fractions
- RADIATION
-
short course treatment
2000 cGy in 4 fractions administered twice a day
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
lead OTHER
Principal Investigators
-
Alessio G Morganti, MD · Radiation Oncology Center, Dept of Experimental, Diagnostic and Speciality Medicine-DIMES, Unviersity of Bologna, S.Orsola-Malpighi Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-08
- Primary Completion
- 2022-11-08
- Completion
- 2023-11-08
Countries
- Italy
Study Locations
More Related Trials
-
Short Course Radiation Therapy in Palliative Treatment of Complicated Bone Metastases
NCT03503682 ·Status: UNKNOWN ·Phase: NA
-
Short Course Radiotherapy in Complicated Bone Metastases Palliation
NCT03455231 ·Status: COMPLETED ·Phase: NA
-
Palliative Short Course Radiotherapy for Advanced Thoracic Cancer
NCT03465553 ·Status: COMPLETED ·Phase: NA
-
Radiotherapy in Palliation of Advanced Pelvic Cancer
NCT03947268 ·Status: COMPLETED ·Phase: NA
-
Short Course Radiation Therapy in Palliative Treatment
NCT03196700 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Toxicities in Patients Treated With Palliative Radiotherapy at Policlinico Sant Orsola of Bologna.
NCT06760806 ·Status: RECRUITING
-
2D-radiotherapy in Palliation of Advanced Esophageal Cancer
NCT03922152 ·Status: COMPLETED ·Phase: NA
-
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma
NCT03269227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Trial to Improve Quality of Life With Stereotactic Body Radiotherapy for Patients With Painful Bone Metastases
NCT03831243 ·Status: COMPLETED ·Phase: NA
-
Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
NCT05229575 ·Status: UNKNOWN ·Phase: NA
-
Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial
NCT03077854 ·Status: UNKNOWN ·Phase: NA
-
Radiotherapy Treatments for the Treatment of Thoracic District Tumors
NCT06335290 ·Status: RECRUITING
-
Prospecitve Observational Study on a Risk Adaptive Scheme for SBRT for Thoracic Nodes Metastases
NCT02970955 ·Status: COMPLETED
-
Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms
NCT06774482 ·Status: RECRUITING
-
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
NCT06391242 ·Status: RECRUITING ·Phase: PHASE3
-
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
NCT03825510 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Radiotherapy for Diffuse Large B-cell Lymphoma
NCT02803840 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparing Palliative Radiotherapy With or Without Carboplatin
NCT03637335 ·Status: TERMINATED ·Phase: PHASE3
-
The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease
NCT04122469 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Radiotherapy (SBRT) of Lung Metastasis
NCT01803542 ·Status: RECRUITING ·Phase: PHASE2
-
SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions
NCT04455438 ·Status: RECRUITING ·Phase: NA
-
Prognosis of Inpatients Evaluated for Palliative Radiotherapy
NCT02312791 ·Status: COMPLETED
-
Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer
NCT06529081 ·Status: RECRUITING ·Phase: NA
-
Cardiopulmonary Toxicity of Thoracic Radiotherapy
NCT03978377 ·Status: RECRUITING
-
Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer
NCT04068649 ·Status: RECRUITING ·Phase: PHASE2